Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata

NCT06564805 is registered in ClinicalTrials.gov with Universidad Autonoma de Nuevo Leon as lead sponsor.

NCT NCT06564805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06564805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
Lead sponsor
Universidad Autonoma de Nuevo Leon
Phase
Not applicable
Overall status
Recruiting
Start date
August 20, 2024
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata